Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment
暂无分享,去创建一个
D. Stewart | S. Archer | J. Grégoire | P. Kessler | N. Dib | F. Charbonneau | F. Mendelsohn | A. Rivard | J. Ducas | H. Rasmussen | J. Hilton | J. Sullivan | C. Buller | S. Plante | J. Macko | E. Cohen | C. Rasmussen | M. Curtis | J. Arnold | P. Page | on behalf of the Revasc Investigators